Viewing Study NCT03781960


Ignite Creation Date: 2025-12-25 @ 2:17 AM
Ignite Modification Date: 2025-12-26 @ 6:20 AM
Study NCT ID: NCT03781960
Status: TERMINATED
Last Update Posted: 2022-12-14
First Post: 2018-12-17
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Abemaciclib and Nivolumab for Subjects With Hepatocellular Carcinoma
Sponsor: Abramson Cancer Center at Penn Medicine
Organization: